Basic Information
| LncRNA/CircRNA Name | AK024094 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qRT-PCR |
| Sample | BCa tissues and cell lines |
| Expression Pattern | up-regulated |
| Function Description | AK024094 aggravates the malignant progression of BCa, and is closely related to tumor staging, distant metastasis, and poor prognosis of BCa. In addition, AK024094 accelerates the proliferation and metastasis of BCa cells by targeting miRNA-181a. |
| Pubmed ID | 32141560 |
| Year | 2020 |
| Title | LncRNA AK024094 aggravates the progression of breast cancer through regulating miRNA-181a |
External Links
| Links for AK024094 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |